CU50+KPV10

CU50+KPV10 (usually included in KLOW or similar peptide formulations) is a designation for a peptide blend or research lyophilized powder.

KPV's Main Efficacy and Mechanism of Action 1. Potent Anti-inflammatory Effect • Mechanism: Reduces the release of pro-inflammatory cytokines (such as TNF-α and IL-6) by inhibiting the NF-κB (nuclear factor κB) signaling pathway. • Characteristics: Unlike traditional immunosuppressants, it does not suppress overall immune function while exerting its anti-inflammatory effect. 2. Intestinal Barrier Repair and Inflammatory Bowel Disease (IBD) Research • Efficacy: Demonstrates improvement in inflammatory bowel diseases such as Crohn's disease and ulcerative colitis in animal models and related studies. • Effects: Supports epithelial barrier integrity, repairs intestinal mucosa, reduces intestinal permeability, and alleviates local oxidative stress. 3. Skin Inflammation and Wound Healing • Skin Diseases: Commonly used in research on inflammatory skin diseases such as eczema, psoriasis, and dermatitis, it can relieve local redness, itching, and skin lesions. • Tissue Repair: Helps accelerate wound healing and supports the regeneration of skin epithelial tissue.

For laboratory research use only. Purity is the store's listed specification; published research is not batch certification.